Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions
US8791131B2 · kind B2 · utility
3Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2009 |
| Grant date | Jul 29, 2014 |
| Priority date | — |
| Expiry date | Sep 18, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of Formula (I),and to salts thereof, their synthesis, and their use as PI3-Kα inhibitors and/or PI3-Kα/mTOR dual inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.